Maria Pia Zappavigna

Title: The Innovative Contributions of Maria Pia Zappavigna

Introduction

Maria Pia Zappavigna, an accomplished inventor based in Magenta, Italy, has made significant strides in the field of medicinal chemistry. With a total of three patents to her name, she is making impactful advancements in the development of treatment options for cardiovascular disorders.

Latest Patents

Among her latest innovations, one notable patent is for "Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders." This patent outlines compounds that are valuable in creating medicaments to treat heart failure and hypertension. The compounds inhibit Na, K-ATPase enzymatic activity, addressing conditions that lead to renal failure progression in autosomal dominant polycystic renal disease (ADPKD), preeclamptic hypertension, and related complications.

Another prominent patent is for "Amino derivatives of beta-homoandrostanes and beta-heteroandrostanes." This patent highlights new aminoalkoxyimino derivatives designed for the treatment of cardiovascular disorders. These compounds, detailed in the patent, have shown potential in pharmaceutical compositions aimed at alleviating heart failure and hypertension.

Career Highlights

Maria Pia Zappavigna currently works for Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., a prominent pharmaceutical company known for its focus on innovative healthcare solutions. Her career has been marked by a dedication to advancing the therapeutic landscape for cardiovascular health and the development of unique medicinal compounds.

Collaborations

In her professional journey, Zappavigna has collaborated with esteemed coworkers, including Alberto Cerri and Patrizia Ferrari. These partnerships have fostered an environment of creativity and innovation, leading to groundbreaking research and the successful filing of impactful patent applications.

Conclusion

Maria Pia Zappavigna represents a remarkable figure in the realm of medicinal innovation. Through her patents and collaborative efforts, she continues to pave the way for novel treatments that target critical cardiovascular disorders. Her contributions are a testament to the power of research and collaboration in improving healthcare outcomes.